1981
DOI: 10.1016/s0009-9260(81)80065-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinico-epidemiological study of Kaposi's sarcoma in Egypt

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
1999
1999

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Limited suc cess was reported by Olweny et al [48] using Rozaxone (ICRF-159). El-Haddad et al [49] showed that cyclophos phamide can be effective, provided it is given after radia tion therapy. Other authors [14,21] failed to demonstrate significant responses with cyclophosphamide.…”
Section: Complicationsmentioning
confidence: 99%
“…Limited suc cess was reported by Olweny et al [48] using Rozaxone (ICRF-159). El-Haddad et al [49] showed that cyclophos phamide can be effective, provided it is given after radia tion therapy. Other authors [14,21] failed to demonstrate significant responses with cyclophosphamide.…”
Section: Complicationsmentioning
confidence: 99%
“…In contrast, Egypt appears to be a country with a low incidence of KS. KS represents less than 1% of all the cancers diagnosed in the country and a minority of all skin tumors (27). Thus, the high prevalence of HHV-8 in Egyptian children is not consistent with the low incidence of KS, suggesting that other cofactors play an important role in the pathogenesis of KS in persons who have no known causes of immunosuppression, such as HIV infection or organ transplants.…”
Section: Discussionmentioning
confidence: 99%